Bacillus_NN Species_NP Are_NP Present_NN in_IN Chewing_NP Tobacco_NP Sold_NP in_IN the_DT United_NP States_NPS and_CC Evoke_NP Plasma_NP Exudation_NP from_IN the_DT Oral_NP Mucosa_NP Five_NP Bacillus_NN species_NNS ,_, predominantly_RB Bacillus_NN megaterium_NN and_CC Bacillus_NN pumilus_NN ,_, were_VBD isolated_VBN from_IN two_CD popular_JJ brands_NNS of_IN commercially_RB available_JJ chewing_VBG tobacco_NN [_SYM (_( 5.0_CD +-_NN 1_LS )_) x_SYM 106_CD CFU/ml_NN of_IN supernatant_JJ ;_: results_NNS for_IN four_CD experiments_NNS ]_SYM ._SENT Moreover_RB ,_, the_DT supernatant_JJ of_IN the_DT Bacillus_NN culture_NN evoked_VBD plasma_NN exudation_NN from_IN postcapillary_JJ venules_NNS in_IN the_DT intact_JJ hamster_NN cheek_NN pouch_NN ,_, exudation_NN that_WDT was_VBD mediated_VBN by_IN the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN ._SENT Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN Bacillus_NN species_NNS contaminate_VBP chewing_VBG tobacco_NN commercially_RB available_JJ in_IN the_DT United_NP States_NPS and_CC elaborate_VB a_DT potent_JJ exogenous_JJ virulence_NN factor(s)_NN that_WDT injures_VBZ the_DT oral_JJ mucosa_NN ._SENT Habitual_JJ use_NN of_IN chewing_VBG tobacco_NN is_VBZ on_IN the_DT rise_NN in_IN the_DT United_NP States_NPS ._SENT This_DT practice_NN may_MD be_VB associated_VBN with_IN oral_JJ mucosa_NN inflammation_NN and_CC injury_NN in_IN susceptible_JJ individuals_NNS and_CC may_MD predispose_VB chewing_VBG tobacco_NN users_NNS to_TO oral_JJ epithelial_JJ cell_NN dysplasia_NN and_CC cancer_NN ._SENT Previous_JJ studies_NNS from_IN our_PP$ laboratory_NN showed_VBD that_IN chewing_VBG tobacco_NN elicits_VBZ plasma_NN exudation_NN from_IN the_DT oral_JJ mucosa_NN by_IN activating_VBG oral_JJ keratinocytes_NNS and_CC the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN ._SENT However_RB ,_, the_DT toxic_JJ constituent(s)_NN of_IN chewing_VBG tobacco_NN that_WDT accounts_VBZ for_IN these_DT responses_NNS has_VBZ not_RB been_VBN characterized_VBN ._SENT A_DT physiological_JJ disorder_NN of_IN the_DT tobacco_NN plant_NN ,_, termed_VBD "_`` frenching_NN ,_, "_'' has_VBZ been_VBN known_VBN to_TO the_DT tobacco_NN industry_NN since_IN colonial_JJ times_NNS ._SENT Although_IN the_DT etiology_NN of_IN this_DT condition_NN is_VBZ uncertain_JJ ,_, so-called_JJ organic_JJ toxins_NNS produced_VBN by_IN Bacillus_NN species_NNS and_CC found_VBN in_IN the_DT soil_NN where_WRB tobacco_NN plants_NNS are_VBP grown_VBN have_VBP been_VBN implicated_VBN ._SENT It_PP is_VBZ conceivable_JJ that_IN Bacillus_NN spores_NNS could_MD contaminate_VB chewing_VBG tobacco_NN processed_VBN for_IN human_JJ use_NN and_CC germinate_VB when_WRB placed_VBN onto_IN the_DT oral_JJ mucosa_NN ._SENT These_DT bacteria_NNS could_MD then_RB elaborate_VB potent_JJ virulence_NN factors_NNS ,_, such_JJ as_IN proteinases_NNS ,_, that_WDT activate_VBP oral_JJ keratinocytes_NNS and_CC the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN in_IN the_DT oral_JJ mucosa_NN ,_, leading_VBG to_TO plasma_NN exudation_NN and_CC tissue_NN injury_NN ._SENT The_DT purpose_NN of_IN this_DT study_NN was_VBD to_TO begin_VB to_TO address_VB this_DT issue_NN by_IN determining_VBG whether_IN Bacillus_NN species_NNS contaminate_VBP commercially_RB available_JJ chewing_VBG tobacco_NN and_CC ,_, if_IN so_RB ,_, whether_IN they_PP evoke_VBP plasma_NN exudation_NN from_IN the_DT intact_JJ oral_JJ mucosa_NN ._SENT Culture_NN of_IN chewing_VBG tobacco_NN ._SENT |_SYM One_CD box_NN each_DT of_IN two_CD popular_JJ chewing_VBG tobacco_NN brands_NNS (_( moist_JJ snuff_NN ;_: Skoal_NP Cherry_NP and_CC Skoal_NP Spearmint_NP [_SYM U.S._NP Tobacco_NP Co._NP ,_, Richmond_NP ,_, Va._NP ]_SYM )_) were_VBD purchased_VBN at_IN a_DT local_JJ grocery_NN store_NN in_IN Chicago_NP ,_, Ill._NP One-half_NP gram_NN of_IN chewing_VBG tobacco_NN from_IN each_DT box_NN was_VBD mixed_VBN with_IN 50_CD ml_NN of_IN sterile_JJ ,_, double-distilled_JJ water_NN for_IN 5_CD min_NN ._SENT Then_RB samples_NNS of_IN the_DT mixture_NN were_VBD transferred_VBN onto_IN blood_NN ,_, mannitol_NN salt_NN ,_, and_CC MacConkey_NP agar_NN plates_NNS by_IN sterile_JJ cotton_NN swabs_NNS and_CC streaked_VBN for_IN isolated_JJ colonies_NNS ._SENT The_DT blood_NN and_CC mannitol_NN salt_NN agar_NN plates_NNS were_VBD incubated_VBN under_IN aerobic_JJ ,_, anaerobic_JJ ,_, and_CC 10_CD %_NN CO2_JJ conditions_NNS ._SENT MacConkey_NP agar_NN plates_NNS were_VBD incubated_VBN aerobically_RB at_IN 37C_JJ ._SENT After_IN 48_CD h_NN ,_, the_DT cultures_NNS were_VBD examined_VBN and_CC a_DT Gram_NP stain_NN of_IN the_DT isolated_JJ colonies_NNS was_VBD performed_VBN ._SENT After_IN an_DT additional_JJ 48_CD h_NN of_IN incubation_NN 13_CD biochemical_JJ tests_NNS were_VBD conducted_VBN to_TO identify_VB the_DT isolated_JJ gram-positive_NN ,_, spore-forming_VBG Bacillus_NN species_NNS ._SENT A_DT viable_JJ count_NN was_VBD done_VBN to_TO determine_VB the_DT number_NN of_IN organisms_NNS present_JJ in_IN each_DT sample_NN ._SENT The_DT most_RBS frequently_RB isolated_VBN Bacillus_NN species_NNS was_VBD inoculated_VBN into_IN 7_CD ml_NN of_IN Trypticase_NP soy_NN broth_NN and_CC incubated_VBN for_IN 72_CD h_NN ._SENT Thereafter_RB ,_, the_DT culture_NN was_VBD centrifuged_VBN (_( 15,000_CD x_SYM g_NN )_) ,_, and_CC the_DT supernatant_JJ was_VBD filtered_VBN through_IN a_DT 0.22-mum-pore-size_JJ filter_NN ,_, snap-frozen_VBN in_IN liquid_JJ nitrogen_NN ,_, and_CC stored_VBD at_IN -70C_NN until_IN used_JJ (_( see_VB below_IN )_) ._SENT Determination_NN of_IN macromolecular_JJ efflux_NN from_IN the_DT oral_JJ mucosa_NN ._SENT |_SYM To_TO determine_VB the_DT effects_NNS of_IN the_DT Bacillus_NN supernatant_JJ on_IN plasma_NN exudation_NN from_IN the_DT intact_JJ oral_JJ mucosa_NN ,_, we_PP used_VBD the_DT in_IN situ_NN microcirculation_NN of_IN the_DT hamster_NN cheek_NN pouch_NN as_IN previously_RB described_VBN in_IN our_PP$ laboratory_NN and_CC by_IN other_JJ investigators_NNS (_( ,_, ,_, ,_, -_: ,_, )_) ._SENT Briefly_RB ,_, we_PP used_VBD adult_JJ ,_, male_JJ golden_JJ Syrian_JJ hamsters_NNS (_( mean_JJ body_NN weight_NN ,_, 130_CD +-_NN 1_CD g_NN )_) that_WDT had_VBD been_VBN anesthetized_VBN with_IN pentobarbital_JJ sodium_NN and_CC on_IN which_WDT tracheostomics_NNS had_VBD been_VBN performed_VBN ._SENT The_DT cheek_NN pouch_NN microcirculation_NN was_VBD visualized_VBN with_IN a_DT fluorescence_NN microscope_NN (_( magnification_NN ,_, x40_NP )_) ._SENT Macromolecular_JJ leakage_NN was_VBD determined_VBN by_IN extravasation_NN of_IN fluorescein_NN isothiocyanate-labeled_JJ dextran_NN (_( FITC-dextran_NP ;_: molecular_JJ mass_NN ,_, 70_CD kDa_NNS )_) ,_, the_DT intravascular_JJ tracer_NN ,_, which_WDT appeared_VBD as_IN fluorescent_JJ spots_NNS or_CC leaky_JJ sites_NNS around_IN postcapillary_JJ venules_NNS ._SENT The_DT number_NN of_IN leaky_JJ sites_NNS in_IN three_CD random_JJ microscopic_JJ fields_NNS was_VBD counted_VBN ,_, averaged_VBD ,_, and_CC expressed_VBD as_IN the_DT number_NN of_IN leaky_JJ sites_NNS per_IN 0.11_CD cm2_NN of_IN cheek_NN pouch_NN ,_, which_WDT corresponds_VBZ to_TO the_DT area_NN of_IN one_CD microscopic_JJ field_NN (_( ,_, ,_, ,_, -_: ,_, )_) ._SENT With_IN a_DT spectrophotofluorometer_NN ,_, the_DT concentration_NN of_IN FITC-dextran_NP in_IN the_DT plasma_NN and_CC suffusate_NNS was_VBD determined_VBN based_VBN on_IN a_DT standard_JJ curve_NN of_IN FITC-dextran_NP concentration_NN versus_CC percent_NN emission_NN ._SENT The_DT clearance_NN of_IN FITC-dextran_NP was_VBD determined_VBN by_IN calculating_VBG the_DT ratio_NN of_IN the_DT concentration_NN of_IN FITC-dextran_NP in_IN suffusate_NN (_( nanograms_NNS per_IN milliliter_NN )_) to_TO that_DT in_IN plasma_NN (_( milligrams_NNS per_IN milliliter_NN )_) and_CC multiplying_VBG this_DT ratio_NN by_IN the_DT suffusate_JJ flow_NN rate_NN (_( 2_CD ml/min_NN )_) ._SENT The_DT experimental_JJ design_NN has_VBZ been_VBN used_VBN previously_RB in_IN our_PP$ laboratory_NN (_( ,_, ,_, -_: ,_, )_) ._SENT After_IN the_DT buffer_NN was_VBD suffused_VBN for_IN 30_CD min_NN (_( the_DT equilibration_NN period_NN )_) ,_, FITC-dextran_NP was_VBD injected_VBN intravenously_RB and_CC the_DT number_NN of_IN leaky_JJ sites_NNS and_CC the_DT clearance_NN of_IN FITC-dextran_NP were_VBD determined_VBN for_IN 30_CD min_NN ._SENT Next_RB ,_, the_DT Bacillus_NN supernatant_JJ (_( 1:1,000_CD dilution_NN in_IN bicarbonate_NN buffer_NN ,_, pH_NN 7.4_CD )_) was_VBD suffused_VBN over_IN the_DT cheek_NN pouch_NN for_IN 20_CD min_NN ._SENT The_DT number_NN of_IN leaky_JJ sites_NNS was_VBD determined_VBN every_DT minute_NN for_IN 20_CD min_NN and_CC at_IN 5-min_JJ intervals_NNS for_IN 60_CD min_NN thereafter_RB ._SENT The_DT clearance_NN of_IN FITC-dextran_NP was_VBD determined_VBN before_IN the_DT application_NN of_IN the_DT supernatant_JJ and_CC every_DT 5_CD min_NN after_IN for_IN 60_CD min_NN ._SENT In_IN another_DT group_NN of_IN animals_NNS ,_, 1_CD muM_NN Hoe140_NP or_CC 1_CD muM_NN NPC_NP 17647_CD ,_, both_CC structurally_RB distinct_JJ selective_JJ bradykinin_NN B2_NN receptor_NN antagonists_NNS (_( ,_, ,_, -_: )_) ,_, was_VBD suffused_VBN over_IN the_DT check_NN pouch_NN for_IN 30_CD min_NN before_IN the_DT check_NN pouch_NN was_VBD suffused_VBN with_IN the_DT Bacillus_NN supernatant_JJ (_( 1:1,000_CD dilution_NN in_IN bicarbonate_NN buffer_NN ,_, pH_NN 7.4_CD )_) for_IN 20_CD min_NN ._SENT The_DT observer_NN of_IN the_DT cheek_NN pouch_NN microcirculation_NN was_VBD unaware_JJ which_WDT hamster_NN belonged_VBD in_IN which_WDT treatment_NN group_NN ._SENT In_IN preliminary_JJ studies_NNS ,_, we_PP determined_VBD that_DT suffusion_NN of_IN bicarbonate_NN buffer_NN (_( vehicle_NN )_) or_CC of_IN a_DT 1:1,000_CD dilution_NN of_IN the_DT bacteriological_JJ medium_NN in_IN bicarbonate_NN buffer_NN (_( pH_NN 7.4_CD )_) for_IN the_DT entire_JJ duration_NN of_IN the_DT experiment_NN or_CC for_IN 20_CD min_NN ,_, respectively_RB ,_, was_VBD associated_VBN with_IN no_DT visible_JJ leaky-site_NN formation_NN and_CC no_DT significant_JJ increase_NN in_IN the_DT clearance_NN of_IN FITC-dextran_NP (_( four_CD animals_NNS ;_: P_NN >_SYM 0.5_CD )_) ._SENT The_DT concentration_NN of_IN the_DT Bacillus_NN supernatant_JJ used_VBN in_IN these_DT experiments_NNS was_VBD based_VBN on_IN preliminary_JJ experiments_NNS ._SENT The_DT concentrations_NNS of_IN Hoe140_NP and_CC NPC_NP 17647_CD used_VBN in_IN these_DT experiments_NNS were_VBD based_VBN on_IN previous_JJ studies_NNS in_IN our_PP$ laboratory_NN ._SENT Chemicals_NNS and_CC drugs_NNS ._SENT |_SYM FITC-dextran_NP was_VBD obtained_VBN from_IN Sigma_NP Chemical_NP Co._NP Hoe140_NP and_CC NPC_NP 17647_CD were_VBD gifts_NNS from_IN Aventis_NP Pharmaceuticals_NPS and_CC Nova_NP Pharmaceutical_NP Corporation_NP ,_, respectively_RB ._SENT All_DT drugs_NNS were_VBD dissolved_VBN in_IN saline_NN ._SENT Drugs_NNS were_VBD prepared_VBN fresh_JJ before_IN each_DT experiment_NN and_CC were_VBD diluted_VBN in_IN saline_NN to_TO the_DT desired_VBN concentrations_NNS ._SENT Data_NNS and_CC statistical_JJ analyses_NNS ._SENT |_SYM When_WRB a_DT test_NN compound_NN was_VBD suffused_VBN over_IN the_DT cheek_NN pouch_NN ,_, we_PP determined_VBD the_DT maximal_JJ change_NN in_IN the_DT number_NN of_IN leaky_JJ sites_NNS and_CC the_DT clearance_NN of_IN FITC-dextran_NP and_CC noted_VBD it_PP as_IN the_DT response_NN to_TO that_DT compound_NN ._SENT Data_NNS are_VBP expressed_VBN as_IN means_NN +-_NN standard_JJ errors_NNS of_IN the_DT means_NN ,_, except_IN for_IN body_NN weight_NN ,_, which_WDT is_VBZ expressed_VBN as_IN mean_JJ +-_NN standard_NN deviation_NN ._SENT Statistical_JJ analysis_NN was_VBD performed_VBN using_VBG two-way_JJ analysis_NN of_IN variance_NN and_CC the_DT Newman-Keuls_NNS test_NN for_IN multiple_JJ comparisons_NNS (_( StatView_NP ;_: SAS_NP Institute_NP Inc._NP ,_, Cary_NP ,_, N.C._NP )_) on_IN a_DT personal_JJ computer_NN ._SENT A_DT P_NN of_IN <0.05_NN was_VBD considered_VBN statistically_RB significant_JJ ._SENT Culture_NN of_IN chewing_VBG tobacco_NN ._SENT |_SYM Gram_NP stain_NN of_IN cultures_NNS of_IN both_DT brands_NNS of_IN chewing_VBG tobacco_NN revealed_VBD large_JJ gram-positive_NN ,_, spore-forming_VBG bacilli_NNS in_IN all_DT samples_NNS (_( four_CD separate_JJ experiments_NNS were_VBD conducted_VBN in_IN duplicate_NN )_) ._SENT Biochemical_JJ analysis_NN of_IN these_DT isolates_NNS revealed_VBD the_DT presence_NN of_IN five_CD distinct_JJ species_NNS of_IN Bacillus_NN ,_, i.e._FW ,_, eight_CD isolates_NNS of_IN Bacillus_NN megaterium_NN ,_, six_CD of_IN Bacillus_NN pumilus_NN ,_, five_CD of_IN Bacillus_NN brevis_NN ,_, two_CD of_IN Bacillus_NN licheniformis_NNS ,_, and_CC one_CD of_IN Bacillus_NN subtilis_NNS in_IN the_DT four_CD experiments_NNS ._SENT The_DT mean_JJ colony_NN count_NN was_VBD (_( 5.0_CD +-_NN 1.0_CD )_) x_SYM 106_CD CFU/ml_NN of_IN supernatant_JJ (_( 7.0_CD x_SYM 106_CD CFU/ml_NN for_IN experiments_NNS 1_CD and_CC 2_CD ,_, 3.0_CD x_SYM 106_CD CFU/ml_NN for_IN experiment_NN 3_CD ,_, and_CC 2.1_CD x_SYM 106_CD CFU/ml_NN for_IN experiment_NN 4_CD )_) ._SENT No_DT other_JJ bacteria_NNS were_VBD isolated_VBN from_IN either_DT brand_NN of_IN chewing_VBG tobacco_NN ._SENT Determination_NN of_IN macromolecular_JJ efflux_NN from_IN the_DT oral_JJ mucosa_NN ._SENT |_SYM Suffusion_NN of_IN saline_JJ (_( vehicle_NN )_) alone_RB for_IN the_DT entire_JJ duration_NN of_IN the_DT experiment_NN evoked_VBD no_DT visible_JJ leaky-site_NN formation_NN and_CC no_DT significant_JJ increase_NN from_IN baseline_NN in_IN the_DT clearance_NN of_IN FITC-dextran_NP (_( four_CD animals_NNS ;_: P_NN >_SYM 0.5_CD )_) ._SENT Repeated_JJ suffusions_NNS of_IN B._NP megaterium_NN supernatant_JJ (_( 1:1,000_CD dilution_NN in_IN bicarbonate_NN buffer_NN ,_, pH_NN 7.4_CD )_) for_IN 20_CD min_NN ,_, each_DT with_IN 30-min_JJ suffusions_NNS of_IN saline_NN in_IN between_IN ,_, were_VBD associated_VBN with_IN significant_JJ and_CC reproducible_JJ leaky-site_JJ formation_NN [_SYM (_( 5.4_CD +-_NN 0.9)/0.11_JJ cm2_NN and_CC (_( 6.0_CD +-_NN 1.1)/0.11_JJ cm2_NN ;_: each_DT group_NN contained_VBD four_CD animals_NNS ;_: P_NN <_0.05 0.5_CD for_IN within-group_NN comparisons_NNS ]_SYM and_CC an_DT increase_NN in_IN the_DT clearance_NN of_IN FITC-dextran_NP [_SYM (_( 25.2_CD +-_NN 7.5_CD ml)/min_NN x_SYM 10-6_CD and_CC (_( 26.9_CD +-_NN 5.9_CD )_) ml/min_NP x_SYM 10-6_CD ;_: each_DT group_NN contained_VBD four_CD animals_NNS ,_, P_NN <_0.05 0.5_CD for_IN within-group_NN comparisons_NNS )_) ._SENT Leaky-site_NP formation_NN was_VBD visible_JJ within_IN 7_CD to_TO 8_CD min_NN after_IN the_DT start_NN of_IN suffusion_NN and_CC was_VBD maximal_JJ 4_CD to_TO 5_CD min_NN after_IN the_DT suffusion_NN of_IN B._NP megaterium_NN supernatant_JJ was_VBD stopped_VBN ._SENT The_DT number_NN of_IN leaky_JJ sites_NNS and_CC the_DT clearance_NN of_IN FITC-dextran_NP returned_VBD to_TO baseline_NN 20_CD min_NN after_IN the_DT suffusion_NN of_IN B._NP megaterium_NN supernatant_JJ was_VBD stopped_VBN ._SENT Repeated_JJ suffusions_NNS of_IN 1_CD muM_NN Hoe140_NP or_CC 1_CD muM_NN NPC_NP 17647_CD alone_RB for_IN 30_CD min_NN ,_, like_IN suffusion_NN of_IN saline_NN alone_RB ,_, evoked_VBD no_DT visible_JJ leaky-site_NN formation_NN and_CC no_DT significant_JJ increase_NN from_IN baseline_NN in_IN the_DT clearance_NN of_IN FITC-dextran_NP (_( each_DT group_NN contained_VBD four_CD animals_NNS ;_: P_NN >_SYM 0.5_CD )_) ._SENT Suffusion_NN of_IN Hoe140_NP and_CC NPC_NP 17647_CD (_( 1_CD muM_NN each_DT )_) for_IN 30_CD min_NN significantly_RB attenuated_VBN B._NP megaterium_NN supernatant-induced_VBD leaky-site_JJ formation_NN and_CC the_DT increase_NN in_IN clearance_NN of_IN FITC-dextran_NP from_IN the_DT cheek_NN pouch_NN (_( each_DT group_NN contained_VBD four_CD animals_NNS ;_: P_NN <_SYM 0.05_CD in_IN comparison_NN to_TO results_NNS for_IN B._NP megaterium_NN supernatant_JJ alone_RB )_) ._SENT FIG._NN 1_CD ._SENT |_SYM Effects_NN of_IN B._NP megaterium_NN Effects_NNS of_IN B._NP megaterium_NN supernatant_JJ (_( 1:1,000_CD dilution_NN in_IN bicarbonate_NN buffer_NN ,_, pH_NN 7.4_CD ;_: CT_NP Bacillus_NN )_) ,_, suffused_VBN for_IN 20_CD min_NN onto_IN the_DT intact_JJ hamster_NN cheek_NN pouch_NN ,_, on_IN leaky-site_NN formation_NN (_( A_NP )_) and_CC the_DT clearance_NN of_IN FITC-dextran_NP (_( molecular_JJ mass_NN ,_, 70_CD kDa_NNS )_) (_( B_NP )_) in_IN the_DT absence_NN and_CC presence_NN of_IN Hoe140_NP and_CC NPC_NP 17647_CD (_( 1_CD muM_NN each_DT )_) ,_, two_CD structurally_RB distinct_JJ selective_JJ bradykinin_NN B2_NN receptor_NN antagonists_NNS ._SENT Data_NNS are_VBP given_VBN as_IN means_NN +-_NN standard_JJ errors_NNS of_IN the_DT means_NNS and_CC represent_VB maximal_JJ values_NNS observed_VBD 5_CD min_NN after_IN the_DT suffusion_NN of_IN the_DT supernatant_JJ was_VBD stopped_VBN ._SENT Each_DT group_NN contained_VBD four_CD animals_NNS ._SENT *_SYM ,_, P_NN of_IN <0.05_NN in_IN comparison_NN to_TO results_NNS with_IN saline_NN ;_: +_SYM ,_, P_NN of_IN <0.05_NN in_IN comparison_NN to_TO results_NNS with_IN B._NP megaterium_NN supernatant_JJ alone_RB ._SENT This_DT study_NN produced_VBD two_CD new_JJ findings_NNS ._SENT First_RB ,_, we_PP found_VBD that_IN five_CD distinct_JJ Bacillus_NN species_NNS ,_, predominantly_RB B._NP megaterium_NP and_CC B._NP pumilus_NN ,_, contaminate_VB ,_, in_IN relatively_RB large_JJ numbers_NNS ,_, two_CD popular_JJ brands_NNS of_IN chewing_VBG tobacco_NN commercially_RB available_JJ in_IN the_DT United_NP States_NPS ._SENT Second_RB ,_, suffusion_NN of_IN a_DT diluted_JJ B._NP megaterium_NN supernatant_JJ onto_IN an_DT intact_JJ hamster_NN cheek_NN pouch_NN ,_, an_DT established_JJ animal_NN model_NN for_IN studying_VBG the_DT mechanisms_NNS underlying_VBG the_DT deleterious_JJ effects_NNS of_IN smokeless_JJ tobacco_NN in_IN the_DT oral_JJ mucosa_NN ,_, significantly_RB increases_VBZ macromolecular_JJ efflux_NN from_IN the_DT cheek_NN pouch_NN ._SENT This_DT response_NN was_VBD mediated_VBN by_IN local_JJ elaboration_NN of_IN bradykinin_NN ,_, because_IN Hoe140_NP and_CC NPC_NP 17647_CD ,_, two_CD structurally_RB distinct_JJ selective_JJ bradykinin_NN B2_NN receptor_NN antagonists_NNS (_( ,_, ,_, -_: )_) ,_, significantly_RB attenuated_VBN B._NP megaterium_NN supernatant-induced_JJ responses_NNS ._SENT Taken_VBN together_RB ,_, these_DT data_NNS indicate_VBP that_IN Bacillus_NN species_NNS contaminate_VBP commercially_RB available_JJ chewing_VBG tobacco_NN and_CC elaborate_VB a_DT potent_JJ exogenous_JJ virulence_NN factor(s)_NN that_WDT activates_VBZ the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN in_IN the_DT intact_JJ oral_JJ mucosa_NN ._SENT This_DT ,_, in_IN turn_NN ,_, evokes_VBZ plasma_NN exudation_NN from_IN postcapillary_JJ venules_NNS ,_, which_WDT leads_VBZ to_TO interstitial_JJ edema_NN and_CC tissue_NN dysfunction_NN ._SENT Whether_IN Bacillus_NN species_NNS contaminate_VBP other_JJ brands_NNS of_IN commercially_RB available_JJ chewing_VBG tobacco_NN remains_VBZ to_TO be_VB determined_VBN ._SENT The_DT mechanisms_NNS underlying_VBG bradykinin_NN production_NN by_IN B._NP megaterium_NN supernatant_JJ in_IN the_DT intact_JJ hamster_NN cheek_NN pouch_NN were_VBD not_RB elucidated_VBN ._SENT Nonetheless_RB ,_, the_DT results_NNS of_IN this_DT study_NN indicate_VBP that_IN a_DT potent_JJ bacterium-derived_JJ exogenous_JJ virulence_NN factor(s)_NN activates_VBZ the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN in_IN the_DT oral_JJ mucosa_NN to_TO elaborate_VB bradykinin_NN ,_, a_DT potent_JJ edemagenic_JJ mediator_NN ._SENT Previous_JJ studies_NNS have_VBP implicated_VBN proteinases_NNS released_VBN by_IN oral_JJ bacteria_NNS ,_, such_JJ as_IN subtilisin_NP and_CC gingipain_NP RgpA_NP ,_, in_IN bradykinin-induced_JJ oral_JJ mucosa_NN injury_NN and_CC inflammation_NN in_IN vivo_JJ (_( ,_, ,_, -_: )_) ._SENT It_PP remains_VBZ to_TO be_VB determined_VBN whether_IN Bacillus_NN species_NNS contaminating_VBG commercially_RB available_JJ chewing_VBG tobacco_NN elaborate_VB proteinases_NNS that_WDT directly_RB activate_VBP the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN in_IN the_DT oral_JJ mucosa_NN or_CC whether_IN a_DT virulence_NN factor(s)_NN released_VBN by_IN these_DT bacteria_NNS stimulates_VBZ oral_JJ keratinocytes_NNS ,_, the_DT first_JJ cells_NNS in_IN the_DT oral_JJ mucosa_NN exposed_VBN to_TO chewing_VBG tobacco_NN and_CC Bacillus_NN species_NNS ,_, to_TO elaborate_VB proteinases_NNS that_WDT activate_VBP this_DT metabolic_JJ pathway_NN (_( ,_, ,_, -_: )_) ._SENT Likewise_RB ,_, the_DT role_NN of_IN various_JJ chemical_NN constituents_NNS of_IN chewing_VBG tobacco_NN in_IN modulating_VBG the_DT germination_NN and_CC expression_NN of_IN virulence_NN factors_NNS by_IN Bacillus_NN species_NNS in_IN the_DT oral_JJ mucosa_NN should_MD be_VB addressed_VBN ._SENT Notwithstanding_IN the_DT findings_NNS described_VBD above_RB ,_, the_DT relevance_NN of_IN the_DT present_JJ acute_JJ experimental_JJ study_NN of_IN the_DT intact_JJ hamster_NN cheek_NN pouch_NN to_TO oral_JJ mucosa_NN inflammation_NN and_CC injury_NN observed_VBN in_IN susceptible_JJ habitual_JJ chewing_VBG tobacco_NN users_NNS is_VBZ uncertain_JJ ;_: the_DT results_NNS of_IN this_DT study_NN do_VBP not_RB include_VB the_DT number_NN of_IN bacteria_NNS required_VBN to_TO elaborate_VB sufficient_JJ quantities_NNS of_IN soluble_JJ virulence_NN factors_NNS to_TO injure_VB the_DT oral_JJ mucosa_NN or_CC whether_IN Bacillus_NN species_NN spores_NNS and_CC bacteria_NNS adhere_VBP to_TO oral_JJ keratinocytes_NNS (_( ,_, ,_, ,_, -_: ,_, ,_, )_) ._SENT However_RB ,_, habitual_JJ users_NNS consume_VBP relatively_RB large_JJ quantities_NNS of_IN chewing_VBG tobacco_NN continually_RB and_CC spit_VB it_PP out_RP rather_RB than_IN rinsing_VBG their_PP$ mouths_NNS thoroughly_RB after_IN each_DT application_NN ._SENT This_DT practice_NN creates_VBZ a_DT local_JJ environment_NN in_IN the_DT oral_JJ mucosa_NN that_WDT is_VBZ conducive_JJ to_TO the_DT germination_NN of_IN Bacillus_NN species_NN spores_NNS and_CC to_TO the_DT elaboration_NN of_IN soluble_JJ virulence_NN factors_NNS ._SENT Certain_JJ Bacillus_NN species_NNS ,_, including_VBG B._NP licheniformis_NP and_CC B._NP pumilus_NN ,_, isolated_VBN from_IN chewing_VBG tobacco_NN in_IN the_DT present_JJ study_NN ,_, have_VBP been_VBN shown_VBN to_TO cause_VB opportunistic_JJ infections_NNS and_CC pulmonary_JJ inflammation_NN in_IN humans_NNS ._SENT The_DT results_NNS of_IN the_DT present_JJ study_NN extend_VB these_DT observations_NNS by_IN showing_VBG that_IN Bacillus_NN species_NNS contaminating_VBG commercially_RB available_JJ chewing_VBG tobacco_NN elicit_VB oral_JJ mucosa_NN inflammation_NN in_IN experimental_JJ animals_NNS ._SENT Clearly_RB ,_, additional_JJ experimental_JJ and_CC clinical_JJ studies_NNS are_VBP warranted_VBN to_TO address_VB these_DT issues_NNS ._SENT In_IN summary_NN ,_, we_PP found_VBD that_IN five_CD distinct_JJ Bacillus_NN species_NNS ,_, predominantly_RB B._NP megaterium_NP and_CC B._NP pumilus_NN ,_, contaminate_JJ in_IN relatively_RB large_JJ numbers_NNS chewing_VBG tobacco_NN commercially_RB available_JJ in_IN the_DT United_NP States_NPS ._SENT Once_RB germinating_VBG ,_, these_DT bacteria_NNS elaborate_VB a_DT potent_JJ exogenous_JJ virulence_NN factor(s)_NN that_WDT activates_VBZ the_DT kallikrein/kinin_NN metabolic_JJ pathway_NN in_IN the_DT intact_JJ oral_JJ mucosa_NN ,_, leading_VBG to_TO plasma_NN exudation_NN and_CC tissue_NN dysfunction_NN ._SENT 